<DOC>
	<DOCNO>NCT00977457</DOCNO>
	<brief_summary>This trial study side effect best way perform genetic test predict biomarkers recurrence patient prostate cancer undergo surgery . Collecting store sample tissue , blood , body fluid patient test laboratory collect information patient 's health treatment may help doctor learn cancer help predict recurrence prostate cancer</brief_summary>
	<brief_title>Genetic Testing Predicting Biomarkers Recurrence Patients With Prostate Cancer Undergoing Surgery</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To explore performance model predict likelihood biochemical recurrence ( BCR ) . SECONDARY OBJECTIVES : I . To explore performance model predict upgrading upstaging prior surgery . II . To explore performance model improve risk stratification among patient eligible active surveillance . III . To determine whether prostatic massage surgery raise count circulate tumor cell ( CTC ) post-digital rectal exam ( DRE ) blood specimen . OUTLINE : Patients receive prostatic massage undergo digital rectal exam ( DRE ) . Laboratory assessment perform blood sample collect molecular biology test . On day schedule prostatectomy , second blood collection perform prior surgery .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>All men undergo robotic prostatectomy cystoprostatectomy City Hope eligible study Men undergo neoadjuvant treatment Androgen Deprivation Therapy ( ADT ) salvage prostatectomy include brachytherapy exclude</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>